Batra SK - Search Results

1

Afatinib and Temozolomide combination inhibits tumorigenesis by targeting EGFRvIII-cMet signaling in glioblastoma cells.

Vengoji R, Macha MA, Nimmakayala RK, Rachagani S, Siddiqui JA, Mallya K, Gorantla S, Jain M, Ponnusamy MP, Batra SK, Shonka N. Vengoji R, et al. Among authors: batra sk. J Exp Clin Cancer Res. 2019 Jun 18;38(1):266. doi: 10.1186/s13046-019-1264-2. J Exp Clin Cancer Res. 2019. PMID: 31215502 Free PMC article.

2

Pharmacokinetics and biodistribution of genetically engineered antibodies.

Batra SK, Jain M, Wittel UA, Chauhan SC, Colcher D. Batra SK, et al. Curr Opin Biotechnol. 2002 Dec;13(6):603-8. doi: 10.1016/s0958-1669(02)00352-x. Curr Opin Biotechnol. 2002. PMID: 12482521 Review.

3

Genetically engineered antibody fragments and PET imaging: a new era of radioimmunodiagnosis.

Jain M, Batra SK. Jain M, et al. Among authors: batra sk. J Nucl Med. 2003 Dec;44(12):1970-2. J Nucl Med. 2003. PMID: 14660723 Free article. No abstract available.

4

Generation and characterization of anti-MUC4 monoclonal antibodies reactive with normal and cancer cells in humans.

Moniaux N, Varshney GC, Chauhan SC, Copin MC, Jain M, Wittel UA, Andrianifahanana M, Aubert JP, Batra SK. Moniaux N, et al. Among authors: batra sk. J Histochem Cytochem. 2004 Feb;52(2):253-61. doi: 10.1177/002215540405200213. J Histochem Cytochem. 2004. PMID: 14729877

5

Inhibition of MUC4 expression suppresses pancreatic tumor cell growth and metastasis.

Singh AP, Moniaux N, Chauhan SC, Meza JL, Batra SK. Singh AP, et al. Among authors: batra sk. Cancer Res. 2004 Jan 15;64(2):622-30. doi: 10.1158/0008-5472.can-03-2636. Cancer Res. 2004. PMID: 14744777

6

Engineering and characterization of a divalent single-chain Fv angiotensin II fusion construct of the monoclonal antibody CC49.

Wittel UA, Jain M, Goel A, Baranowska-Kortylewicz J, Kurizaki T, Chauhan SC, Agrawal DK, Colcher D, Batra SK. Wittel UA, et al. Among authors: batra sk. Biochem Biophys Res Commun. 2005 Apr 1;329(1):168-76. doi: 10.1016/j.bbrc.2005.01.101. Biochem Biophys Res Commun. 2005. PMID: 15721289

7

The in vivo characteristics of genetically engineered divalent and tetravalent single-chain antibody constructs.

Wittel UA, Jain M, Goel A, Chauhan SC, Colcher D, Batra SK. Wittel UA, et al. Among authors: batra sk. Nucl Med Biol. 2005 Feb;32(2):157-64. doi: 10.1016/j.nucmedbio.2004.11.003. Nucl Med Biol. 2005. PMID: 15721761

8

Pharmacokinetics and biodistribution of 177Lu-labeled multivalent single-chain Fv construct of the pancarcinoma monoclonal antibody CC49.

Chauhan SC, Jain M, Moore ED, Wittel UA, Li J, Gwilt PR, Colcher D, Batra SK. Chauhan SC, et al. Among authors: batra sk. Eur J Nucl Med Mol Imaging. 2005 Mar;32(3):264-73. doi: 10.1007/s00259-004-1664-0. Epub 2004 Oct 2. Eur J Nucl Med Mol Imaging. 2005. PMID: 15791435

9

Cytotoxic effects induced by a combination of cyclopamine and gefitinib, the selective hedgehog and epidermal growth factor receptor signaling inhibitors, in prostate cancer cells.

Mimeault M, Moore E, Moniaux N, Hénichart JP, Depreux P, Lin MF, Batra SK. Mimeault M, et al. Among authors: batra sk. Int J Cancer. 2006 Feb 15;118(4):1022-31. doi: 10.1002/ijc.21440. Int J Cancer. 2006. PMID: 16108016

10

Penetratin improves tumor retention of single-chain antibodies: a novel step toward optimization of radioimmunotherapy of solid tumors.

Jain M, Chauhan SC, Singh AP, Venkatraman G, Colcher D, Batra SK. Jain M, et al. Among authors: batra sk. Cancer Res. 2005 Sep 1;65(17):7840-6. doi: 10.1158/0008-5472.CAN-05-0662. Cancer Res. 2005. PMID: 16140953

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

662 results

Search Page

Filters